Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-388

First 388 Last

Share
Profile

Follow
nippy

11,125 Posts.

699

28/03/24

09:31

Post #: 73097071
Share

Originally posted by Pledge: ↑

The ODAC minutes (in hindsight) is a very poor reflection on Mesoblast. It was all Fred Grossman.......?

Don't go and find the interview SI did shortly after where he loses his shiate........because that is even more eye-opening in retrospect. He regained his composure shortly after and as such, the interview I am referring to 'didn't happen....'.

Humans. Flawed. Who would of thought.

Scientific 'gods' that drop their drawers to take a 'mesenchymal stem cell', just like the rest of us.

I do see your point and I am hopeful that the many meetings since then and the many submissions since then and the many ten's of millions of US dollars spent and the involvement of Krause and the treatment of the kids by the very same cells in the almost 4 years since and the recent agreement of the FDA to accept the revamped BLA would of altered the status that you are referring.

Am I sure? No - Mesoblast doesn't tell us much at all and they have played word games with shareholders and the market for years. It is a freaking joke. I've called this business a hobby farm for years - I'm yet to be shown any different.

What is Mesoblast doing today? Whatever took SI's fancy, after he woke up, scratched his nuts and took a mesenchymal stem cell. And that's just how the whole of Mesoblast likes it!

The market has risen on a swag of circumstantial evidence. I've been burnt by this type of situation by these same people before, but, I tentatively say that I reckon this will soon be a goer. And I suspect/hope that it will go and go and go.

Don't rely on anything I say as this company has a long track record of disappointment and the people running it are from another planet, in another galaxy.

Fool me once, blah, blah, blah.....if this goes bad, this one's on me, as I should of known better.

Expand

Edison had how many light bulb failures before his light bulb moment?

How much did it change the world?

MSB Price at posting: 49.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ABY

Adore Beauty FY24 revenues up 7.4% YoY to $196M

ASX Market Open: Aussie futures fall on overall weak night in the US

CC9

Wyoming could be America's next hard rock battery metal province – and Chariot Corporation can help

AI stocks: What to expect in 2024-25

Talking Australia's very competitive property landscape: Realty Talks

There are more pages in this discussion • 709 more messages in this thread...

First 388 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.11		Change -0.020(1.78%)		Mkt cap ! $1.261B

Open	High	Low	Value	Volume
$1.12	$1.13	$1.09	$4.556M	4.141M

Buyers (Bids)

No.	Vol.	Price($)
2	9590	$1.10

Sellers (Offers)

Price($)	Vol.	No.
$1.11	3132	1

View Market Depth

No.	Vol.	Price($)
1	472	1.120
3	10052	1.100
5	35000	1.090
9	74725	1.085
9	141151	1.080

Price($)	Vol.	No.
1.100	10999	3
1.105	5545	1
1.110	4032	2
1.115	30000	1
1.120	32742	3

Last trade - 16.10pm 18/07/2024 (20 minute delay)

MSB (ASX) Chart

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-388

Adore Beauty FY24 revenues up 7.4% YoY to $196M

ASX Market Open: Aussie futures fall on overall weak night in the US

Wyoming could be America's next hard rock battery metal province – and Chariot Corporation can help

AI stocks: What to expect in 2024-25

Talking Australia's very competitive property landscape: Realty Talks

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-388

Top Stories

Adore Beauty FY24 revenues up 7.4% YoY to $196M

ASX Market Open: Aussie futures fall on overall weak night in the US

Wyoming could be America's next hard rock battery metal province – and Chariot Corporation can help

AI stocks: What to expect in 2024-25

Talking Australia's very competitive property landscape: Realty Talks

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News